• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov20
Jyong Biotech Completes Phase II Clinical Trial of MCS-8
13:57
Apr24
Jyong Biotech Ltd. released FY2024 Q3 earnings on April 23, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.0118
03:00
Jyong Biotech Ltd. released FY2023 Annual Earnings on April 23, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.0614
03:00
Jyong Biotech Ltd. released FY2023 Q3 earnings on April 23 (EST), actual revenue USD 0, actual EPS USD -0.0185
03:00
Jyong Biotech Ltd. released FY2024 Q4 earnings on April 23 Post-Market (EST), actual revenue USD 0, actual EPS USD -0.0118
03:00
Jyong Biotech Ltd. released FY2023 Q4 earnings on April 23, 2025 (EST), with actual revenue of USD 0 and EPS of USD -0.0185
03:00

Schedules & Filings

Schedules
Filings
Jun17
IPO(EST)

Listing Price USD 7.5

Apr23
Earning Release(EST)

FY2024 Q4 Earning Release (USD) Net Income -846.5 K, EPS -0.0118

Oct4
Earning Release(EST)

FY2024 Q2 Earning Release (USD) Net Income -663 K, EPS -0.0092

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
AFJK
88.500
+1,006.25%
+80.500
OCG
10.270
+291.98%
+7.650
NCPL
1.400
+112.48%
+0.741
LGHL
8.050
+85.91%
+3.720
JXG
8.630
+67.90%
+3.490
ATMVR
1.060
+49.49%
+0.351
DBI
7.200
+48.45%
+2.350
HSPO
17.500
+42.28%
+5.200
CYPH
1.620
+39.66%
+0.460
ALEX
20.850
+37.71%
+5.710
View More